NO921569L - Fremgangsmaate for fremstilling av et tablett- eller dragepreparat - Google Patents
Fremgangsmaate for fremstilling av et tablett- eller dragepreparatInfo
- Publication number
- NO921569L NO921569L NO92921569A NO921569A NO921569L NO 921569 L NO921569 L NO 921569L NO 92921569 A NO92921569 A NO 92921569A NO 921569 A NO921569 A NO 921569A NO 921569 L NO921569 L NO 921569L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- sec
- tablet
- known per
- weight
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- -1 alkaline earth metal salt Chemical class 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008240 homogeneous mixture Substances 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Bending Of Plates, Rods, And Pipes (AREA)
- Press Drives And Press Lines (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU905314A HU206824B (en) | 1990-08-24 | 1990-08-24 | Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents |
| PCT/HU1991/000039 WO1992003126A1 (en) | 1990-08-24 | 1991-08-23 | Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO921569D0 NO921569D0 (no) | 1992-04-23 |
| NO921569L true NO921569L (no) | 1992-04-23 |
| NO303669B1 NO303669B1 (no) | 1998-08-17 |
Family
ID=10970061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921569A NO303669B1 (no) | 1990-08-24 | 1992-04-23 | FremgangsmÕte for fremstilling av en tablett eller dragÚpreparat |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5322698A (no) |
| EP (1) | EP0500851B1 (no) |
| JP (1) | JPH0813736B2 (no) |
| KR (1) | KR0177493B1 (no) |
| AT (1) | ATE119388T1 (no) |
| CA (1) | CA2067733C (no) |
| CZ (1) | CZ281577B6 (no) |
| DE (1) | DE69108007T2 (no) |
| DK (1) | DK0500851T3 (no) |
| ES (1) | ES2072617T3 (no) |
| FI (1) | FI103015B1 (no) |
| GR (1) | GR3015719T3 (no) |
| HU (1) | HU206824B (no) |
| IL (1) | IL99237A (no) |
| IN (1) | IN171740B (no) |
| NO (1) | NO303669B1 (no) |
| PT (1) | PT98758B (no) |
| SK (1) | SK278919B6 (no) |
| WO (1) | WO1992003126A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US5399356A (en) * | 1994-03-24 | 1995-03-21 | The Procter & Gamble Company | Process for making solid dose forms containing bismuth |
| US5948438A (en) * | 1995-01-09 | 1999-09-07 | Edward Mendell Co., Inc. | Pharmaceutical formulations having improved disintegration and/or absorptivity |
| US6936277B2 (en) * | 1995-01-09 | 2005-08-30 | J. Rettenmaier & Soehne Gmbh & Co. Kg | Pharmaceutical excipient having improved compressibility |
| US6471994B1 (en) | 1995-01-09 | 2002-10-29 | Edward Mendell Co., Inc. | Pharmaceutical excipient having improved compressibility |
| US5585115A (en) | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
| US6395303B1 (en) | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
| IL116674A (en) * | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
| US6391337B2 (en) | 1995-11-15 | 2002-05-21 | Edward Mendell Co., Inc. | Directly compressible high load acetaminophen formulations |
| US6852336B2 (en) | 1995-11-15 | 2005-02-08 | J. Rettenmaier & Soehne Gmbh + Co. Kg | Directly compressible high load acetaminophen formulations |
| US5733578A (en) | 1995-11-15 | 1998-03-31 | Edward Mendell Co., Inc. | Directly compressible high load acetaminophen formulations |
| EP0901787B1 (en) * | 1997-09-10 | 2003-05-28 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
| GB9910505D0 (en) * | 1999-05-06 | 1999-07-07 | Electrosols Ltd | A method and apparatus for manufacturing consumable tablets |
| RU2220715C2 (ru) * | 1999-08-04 | 2004-01-10 | Яманоути Фармасьютикал Ко., Лтд. | Стабильная пероральная, образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции |
| AU2001291738A1 (en) * | 2000-08-10 | 2002-02-18 | Unihart Corporation | "Slow release" pharmaceutical compositions comprising lithium carbonate |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3907999A (en) * | 1968-01-30 | 1975-09-23 | Merck & Co Inc | Substituted dibenzocyclooctene compositions |
| NL167153C (nl) * | 1968-12-24 | 1981-11-16 | Merck & Co Inc | Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat en werkwijze voor het bereiden van een farmacologisch werkzaam, aan het stikstofatoom gesubstitueerd 5-aminomethyl-5-hydroxy-5h-dibenzoÿa.dÿ- cyclohepteen, geschikt voor gebruik bij de genoemde werkwijze. |
| DE2416903A1 (de) * | 1974-04-06 | 1975-10-09 | Bayer Ag | Verwendung von schmelzverspruehtem kugelfoermigem phenacetingranulat zur herstellung von tabletten im direkttablettierverfahren |
| US4198402A (en) * | 1975-12-17 | 1980-04-15 | Richter Gedeon Vegyeszeti Gyar Rt. | Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment |
| EP0112061A3 (en) * | 1982-11-20 | 1985-08-14 | Beecham Group Plc | Pharmaceutical or veterinary compositions containing guanoxabenz |
| US4517179A (en) * | 1983-04-29 | 1985-05-14 | Pennwalt Corporation | Rapid dissolving, uniform drug compositions and their preparation |
| CA1261261A (en) * | 1985-03-08 | 1989-09-26 | Dev K. Mehra | Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation |
| US4707361A (en) * | 1985-08-02 | 1987-11-17 | Stauffer Chemical Company | Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
-
1990
- 1990-08-24 HU HU905314A patent/HU206824B/hu unknown
-
1991
- 1991-08-20 IN IN629/MAS/91A patent/IN171740B/en unknown
- 1991-08-20 IL IL9923791A patent/IL99237A/en not_active IP Right Cessation
- 1991-08-23 DK DK91915256.1T patent/DK0500851T3/da active
- 1991-08-23 WO PCT/HU1991/000039 patent/WO1992003126A1/en not_active Ceased
- 1991-08-23 JP JP3513683A patent/JPH0813736B2/ja not_active Expired - Fee Related
- 1991-08-23 ES ES91915256T patent/ES2072617T3/es not_active Expired - Lifetime
- 1991-08-23 SK SK2617-91A patent/SK278919B6/sk not_active IP Right Cessation
- 1991-08-23 PT PT98758A patent/PT98758B/pt not_active IP Right Cessation
- 1991-08-23 EP EP91915256A patent/EP0500851B1/en not_active Expired - Lifetime
- 1991-08-23 DE DE69108007T patent/DE69108007T2/de not_active Expired - Lifetime
- 1991-08-23 CZ CS912617A patent/CZ281577B6/cs not_active IP Right Cessation
- 1991-08-23 AT AT91915256T patent/ATE119388T1/de not_active IP Right Cessation
- 1991-08-23 KR KR1019920700937A patent/KR0177493B1/ko not_active Expired - Lifetime
- 1991-08-23 US US07/849,067 patent/US5322698A/en not_active Expired - Lifetime
- 1991-09-23 CA CA002067733A patent/CA2067733C/en not_active Expired - Lifetime
-
1992
- 1992-04-23 FI FI921809A patent/FI103015B1/fi not_active IP Right Cessation
- 1992-04-23 NO NO921569A patent/NO303669B1/no not_active IP Right Cessation
-
1995
- 1995-04-10 GR GR950400851T patent/GR3015719T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI921809A0 (fi) | 1992-04-23 |
| KR927002214A (ko) | 1992-09-03 |
| FI921809L (fi) | 1992-04-23 |
| JPH05503540A (ja) | 1993-06-10 |
| FI103015B (fi) | 1999-04-15 |
| HU905314D0 (en) | 1991-02-28 |
| FI103015B1 (fi) | 1999-04-15 |
| PT98758A (pt) | 1992-07-31 |
| CS261791A3 (en) | 1992-03-18 |
| IL99237A (en) | 1996-01-19 |
| KR0177493B1 (ko) | 1999-03-20 |
| ATE119388T1 (de) | 1995-03-15 |
| PT98758B (pt) | 1999-01-29 |
| ES2072617T3 (es) | 1995-07-16 |
| EP0500851B1 (en) | 1995-03-08 |
| NO921569D0 (no) | 1992-04-23 |
| HU206824B (en) | 1993-01-28 |
| EP0500851A1 (en) | 1992-09-02 |
| US5322698A (en) | 1994-06-21 |
| IN171740B (no) | 1992-12-26 |
| NO303669B1 (no) | 1998-08-17 |
| CZ281577B6 (cs) | 1996-11-13 |
| WO1992003126A1 (en) | 1992-03-05 |
| DE69108007T2 (de) | 1995-07-20 |
| IL99237A0 (en) | 1992-07-15 |
| CA2067733A1 (en) | 1992-02-25 |
| CA2067733C (en) | 2002-03-19 |
| GR3015719T3 (en) | 1995-07-31 |
| DE69108007D1 (de) | 1995-04-13 |
| SK278919B6 (sk) | 1998-04-08 |
| DK0500851T3 (da) | 1995-07-24 |
| JPH0813736B2 (ja) | 1996-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO921569D0 (no) | Fremgangsmaate for fremstilling av et tablett- eller dragepreparat | |
| SE8702907D0 (sv) | Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same | |
| BG102254A (en) | Oral fast soluble compositions as dopamine antagonists | |
| EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
| ES8301967A1 (es) | Procedimiento de preparar compuestos carbostirilicos. | |
| HUT67924A (en) | Fungicidal compositions containing 2-(substituted phenyl)-3-methoxy-propenecarboxylates as active ingredients, process for producing the active ingredients, and method for combatting fungi | |
| IL110582A0 (en) | Substituted azadioxacycloalkenes, their preparation and fungicidal compositions containing them | |
| MD707B2 (en) | Sulphonylurea derivatives, process for their preparation, the intermediate products for them, the herbicide and plants growing suppressing remedy on their base, weeds control process | |
| HUT63542A (en) | Herbicidal compositions comprising substituted arylalkyl sulfonyl pyrazole derivatives as active ingredient, process for exterminating unwanted plants and for producing the active ingredients | |
| ATE220321T1 (de) | Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe | |
| ZA917701B (en) | Heterocycle-substituted alkylamines,process for preparing these and pharmaceutical compositions containing them | |
| ES8103051A1 (es) | Un metodo de preparar nuevos derivados de pirazolina | |
| HUT61746A (en) | Pyridylsulfonylurea derivatives, process for their production, herbicidal and plant growth regulating compositions comprising such compounds as active ingredient, intermediates of the active ingredients and their production | |
| ES8207169A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. | |
| IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
| IL97892A0 (en) | 2,9-disubstituted-4h-pyrido(1,2-a)pyrimidin-4-ones,their preparation and pharmaceutical compositions containing them | |
| HUT49591A (en) | Plant growth regulating and fungicidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredients | |
| HUT70531A (en) | Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them | |
| HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
| HUT68190A (en) | Process for producing ergoline derivatives of serotoninergic activity | |
| HK47592A (en) | Piperazine derivatives | |
| MXPA02006250A (es) | Derivados de butino diol. | |
| ES2006521A6 (es) | Composicion de control de plagas procedimiento derivados benzopiranicos y benzotiopiranicos y metodo de preparar dicha composicion | |
| KR890001559A (ko) | 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도 | |
| HK47492A (en) | Piperazine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |